Advertisement
Loading...

Lasa Supergenerics Limited

LASA.NSNSE
Healthcare
Drug Manufacturers - Specialty & Generic
8.38
0.32(3.97%)
Indian Market opens in 10h 36m
Advertisement

Lasa Supergenerics Limited (LASA.NS) Stock Overview

Explore Lasa Supergenerics Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap411.8M
P/E Ratio-0.93
EPS (TTM)$3.70
ROE-0.56%
Fundamental Analysis

AI Price Forecasts

1 Month$1.09
3 Months$0.00
1 Year Target$0.00

LASA.NS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lasa Supergenerics Limited (LASA.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.43, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.93 and a market capitalization of 411.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.99%
5-Day Change
-3.18%
1-Month Change
2.24%
3-Month Change
4.71%
6-Month Change
-15.61%
Year-to-Date (YTD) Change
-12.92%
1-Year Change
-51.39%
3-Year Change
-64.65%
5-Year Change
-89.59%
All-Time (Max) Change
-94.42%

Contact Information

912249701092
No. 506 & 507, Midas Sahar Plaza, Mumbai, NaN, 400059

Company Facts

770 Employees
IPO DateSep 21, 2017
CountryIN
Actively Trading

Frequently Asked Questions